Sign in

CIK 0001835597 · <br>Emerging growth company

PepGen Inc.

Sign in to watch
Ticker
PEPG
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
703-456-8000
Business address
1 MARINA PARK DRIVE, SUITE 900, BOSTON, MA, 02210
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2023-06-08 McArthur James G President and CEO Sale 10b5-1 −2,381 $16.04 $38K 0
2023-06-08 McArthur James G President and CEO Option exercise · Stock Option (Right to Buy) 10b5-1 −2,381 325,054
2023-06-07 McArthur James G President and CEO Option exercise 10b5-1 +8,419 $2.71 $23K 8,419
2023-06-07 McArthur James G President and CEO Sale 10b5-1 −8,419 $16.23 $137K 0
2023-06-07 McArthur James G President and CEO Option exercise · Stock Option (Right to Buy) 10b5-1 −8,419 327,435
2023-06-06 McArthur James G President and CEO Option exercise 10b5-1 +18,150 $2.71 $49K 18,150
2023-06-06 McArthur James G President and CEO Sale 10b5-1 −18,150 $16.18 $294K 0
2023-06-06 McArthur James G President and CEO Option exercise · Stock Option (Right to Buy) 10b5-1 −18,150 335,854
2023-06-05 McArthur James G President and CEO Option exercise 10b5-1 +500 $2.71 $1K 500
2023-06-05 McArthur James G President and CEO Sale 10b5-1 −500 $16.06 $8K 0
2023-06-05 McArthur James G President and CEO Option exercise · Stock Option (Right to Buy) 10b5-1 −500 354,004
2023-06-02 McArthur James G President and CEO Option exercise 10b5-1 +1,800 $2.71 $5K 1,800
2023-06-02 McArthur James G President and CEO Sale 10b5-1 −1,800 $16.04 $29K 0
2023-06-02 McArthur James G President and CEO Option exercise · Stock Option (Right to Buy) 10b5-1 −1,800 354,504
2023-03-24 Goyal Jaya EVP, Res. & Preclin. Dev. Option exercise +392 $10.88 $4K 392
2023-03-24 Goyal Jaya EVP, Res. & Preclin. Dev. Sale −392 $20.00 $8K 0
2023-03-24 Goyal Jaya EVP, Res. & Preclin. Dev. Option exercise · Stock Option (Right to Buy) −392 143,804
2023-03-01 Mellion Michelle L SVP, Clinical Development Grant or award · Stock Option (Right to Buy) +75,000 75,000
2023-03-01 Mellion Michelle L SVP, Clinical Development Grant or award · Stock Option (Right to Buy) +20,000 95,000
2023-03-01 Goyal Jaya EVP, Res. & Preclin. Dev. Grant or award · Stock Option (Right to Buy) +75,000 75,000

Page 8 of 11 · 211 trades